Guido J H Bastiaens
Overview
Explore the profile of Guido J H Bastiaens including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
776
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
van der Veer C, Apako J, Sonneveld-Hendriks A, Kaak A, Arias-Claro Handgraaf C, Schaftenaar E, et al.
Travel Med Infect Dis
. 2025 Mar;
65:102830.
PMID: 40032187
This study assessed the analytical and clinical performance of the EasyNAT Malaria cross-priming amplification assay and the Alethia Malaria loop-mediated isothermal amplification assay in screening for Plasmodium spp. in febrile...
2.
Bastiaens G, vanGemert G, Hooghof J, Lindsay S, Drakeley C, Churcher T, et al.
Malariaworld J
. 2024 Jun;
3:10.
PMID: 38854885
Background: Ivermectin (IVM) reduces the lifespan of malaria-transmitting mosquitoes after feeding on humans treated with IVM. If this effect is sufficiently long and strong, IVM could form part of a...
3.
Ouedraogo A, Guelbeogo W, Cohuet A, Morlais I, King J, Goncalves B, et al.
Malariaworld J
. 2024 Jun;
4:16.
PMID: 38828116
Mosquito feeding assays play an important role in quantifying malaria transmission potential in epidemiological and clinical studies. At present, membrane feeding assays are incompletely standardised. This affects our understanding of...
4.
Stepniewska K, Allen E, Humphreys G, Poirot E, Craig E, Kennon K, et al.
BMC Med
. 2022 Sep;
20(1):350.
PMID: 36109733
Background: In 2012, the World Health Organization (WHO) recommended single low-dose (SLD, 0.25 mg/kg) primaquine to be added as a Plasmodium (P.) falciparum gametocytocide to artemisinin-based combination therapy (ACT) without...
5.
Flipse J, Tromp A, Bosman J, Ten Hove C, Beks H, Kortbeek T, et al.
Emerg Infect Dis
. 2022 Mar;
28(4):890-892.
PMID: 35318925
An increase in positive Bordetella parapertussis tests among patients in a teaching hospital in the Netherlands resulted in enhanced infection control and microbiological surveillance. Further analysis revealed that batches of...
6.
Spiegelenberg J, Bastiaens G, Hassing R
J Travel Med
. 2021 Jun;
28(5).
PMID: 34104968
No abstract available.
7.
Sepulveda N, Grignard L, Curry J, Mahey L, Bastiaens G, Tiono A, et al.
Front Genet
. 2021 Apr;
12:645688.
PMID: 33897764
Primaquine (PQ) is an antimalarial drug with the potential to reduce malaria transmission due to its capacity to clear mature gametocytes in the human host. However, the large-scale roll-out of...
8.
Stepniewska K, Humphreys G, Goncalves B, Craig E, Gosling R, Guerin P, et al.
J Infect Dis
. 2020 Aug;
225(7):1215-1226.
PMID: 32778875
Background: Since the World Health Organization recommended single low-dose (0.25 mg/kg) primaquine (PQ) in combination with artemisinin-based combination therapies (ACTs) in areas of low transmission or artemisinin-resistant Plasmodium falciparum, several...
9.
Bastiaens G, Baarslag T, Pelgrum C, Mascini E
Antimicrob Resist Infect Control
. 2020 Jan;
9(1):8.
PMID: 31921414
We evaluated a new hospital policy comprising active surveillance for highly resistant microorganisms (HRMO) in patients with prolonged hospitalization, including detection of nosocomial transmission after identification of HRMO carriers. Our...
10.
Achan J, Reuling I, Yap X, Dabira E, Ahmad A, Cox M, et al.
Clin Infect Dis
. 2019 Aug;
70(12):2544-2552.
PMID: 31402382
Background: We assessed the impact of exposure to Plasmodium falciparum on parasite kinetics, clinical symptoms, and functional immunity after controlled human malaria infection (CHMI) in 2 cohorts with different levels...